{"id":"W3003274437","doi":"10.1016/j.jaad.2020.01.056","title":"Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"LEO Pharma; MedImmune; Galderma; Ortho Dermatologics; Dermira; DUSA Pharmaceuticals; Vanda Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Kiniksa Pharmaceuticals; AbbVie; Sun Pharma; Regeneron Pharmaceuticals; Abbott Laboratories; Sanofi; Novartis; Pfizer; Amgen","keywords":"Medicine; Double blind; Placebo; Dermatology; Randomized controlled trial; Clinical trial; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001306197,0.0002855059,0.003471719,0.000145201,0.0001235175,0.000009478877,0.0007627126,0.0003162626,0.00004984513],"category_scores_gemma":[0.00145687,0.0001651698,0.001911226,0.0002455208,0.0009784794,0.00009082033,0.00008584856,0.0006560418,0.00002382761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002400149,"about_ca_system_score_gemma":0.0002639304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004255413,"about_ca_topic_score_gemma":5.899381e-7,"domain_scores_codex":[0.9944929,0.002124301,0.002652176,0.0002477608,0.0001028038,0.0003800248],"domain_scores_gemma":[0.9915115,0.003340934,0.004793257,0.0001549991,0.0001075117,0.00009182946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9811614,0.0005704596,0.0001369059,0.0000278571,0.004292033,0.00001012111,0.0003020099,0.000004577869,0.002603559,0.0005013371,0.004299146,0.006090587],"study_design_scores_gemma":[0.9761028,0.001546054,0.00002119663,0.0000300001,0.002967837,0.0006796264,0.0001677827,0.0000378046,0.007544037,0.0003571915,0.01038808,0.0001576396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9597973,0.003600375,0.0005626405,0.03158648,0.001526559,0.002813307,0.00003495602,0.00001837345,0.00006002856],"genre_scores_gemma":[0.9957585,0.0009522503,0.0006635244,0.001886723,0.0004875934,0.0001390155,0.000005396435,0.00002464997,0.00008234166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03596123,"threshold_uncertainty_score":0.6735427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06953297999972495,"score_gpt":0.3760347833045655,"score_spread":0.3065018033048405,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}